Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration.
Moja L, Lucenteforte E, Kwag KH, Bertele V, Campomori A, Chakravarthy U, D'Amico R, Dickersin K, Kodjikian L, Lindsley K, Loke Y, Maguire M, Martin DF, Mugelli A, Mühlbauer B, Püntmann I, Reeves B, Rogers C, Schmucker C, Subramanian ML, Virgili G. Moja L, et al. Among authors: lucenteforte e. Cochrane Database Syst Rev. 2014 Sep 15;9(9):CD011230. doi: 10.1002/14651858.CD011230.pub2. Cochrane Database Syst Rev. 2014. PMID: 25220133 Free PMC article. Review.
Comparison between Gibson-Cooke and Macroduct Methods in the Cystic Fibrosis Neonatal Screening Program and in Subjects Who Are Cystic Fibrosis Screen-Positive with an Inconclusive Diagnosis.
Dolce D, Fevola C, Camera E, Orioli T, Lucenteforte E, Malanima MA, Taccetti G, Terlizzi V. Dolce D, et al. Among authors: lucenteforte e. Int J Neonatal Screen. 2023 Jul 25;9(3):41. doi: 10.3390/ijns9030041. Int J Neonatal Screen. 2023. PMID: 37606478 Free PMC article.
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis.
Convertino I, Lorenzoni V, Gini R, Turchetti G, Fini E, Giometto S, Bartolini C, Paoletti O, Ferraro S, Cappello E, Valdiserra G, Bonaso M, Blandizzi C, Tuccori M, Lucenteforte E. Convertino I, et al. Among authors: lucenteforte e. Pharmaceuticals (Basel). 2023 Mar 21;16(3):465. doi: 10.3390/ph16030465. Pharmaceuticals (Basel). 2023. PMID: 36986565 Free PMC article.
Multiple systematic reviews: methods for assessing discordances of results.
Moja L, Fernandez del Rio MP, Banzi R, Cusi C, D'Amico R, Liberati A, Lodi G, Lucenteforte E, Minozzi S, Pecoraro V, Virgili G, Parmelli E. Moja L, et al. Among authors: lucenteforte e. Intern Emerg Med. 2012 Dec;7(6):563-8. doi: 10.1007/s11739-012-0846-1. Epub 2012 Sep 2. Intern Emerg Med. 2012. PMID: 22941412 Review.
Discordances originated by multiple meta-analyses on interventions for myocardial infarction: a systematic review.
Lucenteforte E, Moja L, Pecoraro V, Conti AA, Conti A, Crudeli E, Galli A, Gensini GF, Minnelli M, Mugelli A, Proietti R, Shtylla J, D'Amico R, Parmelli E, Virgili G. Lucenteforte E, et al. J Clin Epidemiol. 2015 Mar;68(3):246-56. doi: 10.1016/j.jclinepi.2014.11.004. Epub 2014 Nov 13. J Clin Epidemiol. 2015. PMID: 25533151 Free article. Review.
Optic nerve head and fibre layer imaging for diagnosing glaucoma.
Michelessi M, Lucenteforte E, Oddone F, Brazzelli M, Parravano M, Franchi S, Ng SM, Virgili G. Michelessi M, et al. Among authors: lucenteforte e. Cochrane Database Syst Rev. 2015 Nov 30;2015(11):CD008803. doi: 10.1002/14651858.CD008803.pub2. Cochrane Database Syst Rev. 2015. PMID: 26618332 Free PMC article. Review.
159 results